Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_178040.4(ERC1):c.64C>T(p.Pro22Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000929 in 1,613,962 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
ERC1 (HGNC:17072): (ELKS/RAB6-interacting/CAST family member 1) The protein encoded by this gene is a member of a family of RIM-binding proteins. RIMs are active zone proteins that regulate neurotransmitter release. This gene has been found fused to the receptor-type tyrosine kinase gene RET by gene rearrangement due to the translocation t(10;12)(q11;p13) in thyroid papillary carcinoma. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014]
Review Status: criteria provided, single submitter
Collection Method: clinical testing
The c.64C>T (p.P22S) alteration is located in exon 1 (coding exon 1) of the ERC1 gene. This alteration results from a C to T substitution at nucleotide position 64, causing the proline (P) at amino acid position 22 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Gain of phosphorylation at P22 (P = 6e-04);Gain of phosphorylation at P22 (P = 6e-04);Gain of phosphorylation at P22 (P = 6e-04);Gain of phosphorylation at P22 (P = 6e-04);Gain of phosphorylation at P22 (P = 6e-04);Gain of phosphorylation at P22 (P = 6e-04);Gain of phosphorylation at P22 (P = 6e-04);Gain of phosphorylation at P22 (P = 6e-04);Gain of phosphorylation at P22 (P = 6e-04);